BAO PHARMA-B (02659) announced that it repurchased 184,800 shares on August 31, 2026, for a total consideration of approximately HK$2.9912 million.
The buyback was executed at a per-share price ranging from HK$15.69 to HK$16.66.
BAO PHARMA-B (02659) announced that it repurchased 184,800 shares on August 31, 2026, for a total consideration of approximately HK$2.9912 million.
The buyback was executed at a per-share price ranging from HK$15.69 to HK$16.66.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.